About
Neurodiagnostics
Areas of Focus
Categories
DiagnosticsNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
400
By Phase
NA: 4
By Status
SUSPENDED: 2COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT00529945Lead Sponsor
PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness
NASuspended
200 participants
Started: Aug 31, 2007 · Completed: Dec 31, 2007
NCT00335296Lead Sponsor
PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)
NASuspended
100 participants
Started: May 31, 2006 · Completed: Dec 31, 2007
NCT00196040Lead Sponsor
The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness
NACompleted
60 participants
Started: Oct 31, 2005 · Completed: Nov 30, 2007
NCT00196027Lead Sponsor
Paradigm I Clinical Trial: Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemia Attack or Paradoxical Embolism
NAUnknown
40 participants
Started: Apr 30, 2005
Locations (1)
Headquarters
Bethlehem, PA, United States
Map
Loading map...